IgM-anti-HBc as a marker of persistent and IgG-anti-HBc as a marker of past hepatitis B infection. a longitudinal study over 5 years
Niermeiier, P.; Gips, C.H.; Huizenga, J.R.; Ringers, J.; Verkerk, S.; Houthuff, H.J.; Houwen, B.; Snijder, J.A.; Nielsen, J.O.
Acta Hepato-Gastroenterologica 25(5): 360-364
1978
ISSN/ISBN: 0300-970X PMID: 726802 Document Number: 128564
Document emailed within 1 workday
Related Documents
Lebacq, A.M.; Goffinet, P.; De Bruyere, M.; Rodhain, J.; Sokal, G. 1982: Membrane marker studies with anti-T, anti-Ia (DR) and anti-myeloblast antisera in acute leukaemias European Journal of Cancer and Clinical Oncology 18(2): 147-153Pintera, J.; Vacl, J. 1977: Anti-HBbrno: a new CIEP hepatitis B marker, more sensitive than HBsAg radioimmunoassay Folia Haematologica 104(1): 123-132
Thiers, V.; Bouchardeau, F.; Courouce, A.M.; Tiollais, P.; Brechot, C. 1986: Hepatitis B virus DNA as a marker of viral multiplication: comparison with HBe antigen and anti-HBe antibody Presse Medicale 15(26): 1219-1222
Altcheh, J.; Corral, R.; Biancardi, M.A.; Freilij, H.éc. 2003: Anti-F2/3 antibodies as cure marker in children with congenital Trypanosoma cruzi infection Medicina 63(1): 37-40
Nebel-Schickel, H.; Hinderer, W.; Saavedra, C.; Schmutzler, R.; Horn, J.; Vornhagen, R.; Sonneborn, H.H. 1994: Anti-EBNA-1 (carboxy-half) IgG antibodies as a seroepidemiological marker for Epstein-Barr virus infection Beitrage Zur Infusionstherapie und Transfusionsmedizin 32: 134-137
Ogutu, E.O.; Amayo, E.O.; Okoth, F.; Lule, G.N. 1990: The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS) East African Medical Journal 67(5): 355-358
Ogutu, E.O.; Amayo, E.O.; Okoth, F.; Lule, G.N. 1990: The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS) East African Medical Journal 67(5): 355-358
Kinoshita, M. 1990: Anti-Jo-1 antibody and anti-aminoacyl-tRNA synthetase antibody as a marker autoantibody for myositis Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 482-484
Kano, S. 1999: Serological diagnosis of streptococcal infection (anti-streptolysin O; ASO, anti-streptokinase; ASK, anti-deoxyribonuclease B; ADNB, anti-hyaluronidase; AHD, anti-streptococcal polysaccharide; ASP) Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 107-116
Kurl, A.; Berry, V.; Dhanoa, J.; Masih, A. 2007: Seropositivity of HBsAg, anti HCV and anti HIV among blood donors: a comparative study on three years of 5 years interval Indian journal of public health 51(1): 41-42
Koskela, S.; Tapanainen, J. 2016: Anti-Müllerian hormone - a marker of ovarian function Duodecim; Laaketieteellinen Aikakauskirja 132(3): 226-232
Rauch, J.; Murphy, E.; Roths, J.B.; Stollar, B.D.; Schwartz, R.S. 1982: A high frequency idiotypic marker of anti-DNA autoantibodies in MRL-Ipr/Ipr mice Journal of Immunology 129(1): 236-241
Jennette, J.C.; Falk, R.J.; Wilkman, A.S. 1995: Anti-neutrophil cytoplasmic autoantibodies--a serologic marker for vasculitides Annals of the Academy of Medicine Singapore 24(2): 248-253
Ricciardi, G.; Graziano, G. 1990: Safety and immunogenicity of an anti-hepatitis-B vaccine obtained using the recombinant DNA technique: results of a longitudinal study in hospital personnel Bollettino dell'Istituto Sieroterapico Milanese 69(2): 385-390
Matsuda, J.; Saitoh, N.; Gotoh, M.; Gohchi, K.; Tsukamoto, M.; Syoji, S.; Miyake, K.; Yamanaka, M. 1995: High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha American Journal of Gastroenterology 90(7): 1138-1141
Haliassos, A.; Melita-Manolis, H.; Aggelaki, D.; Tassi, D.; Terzoglou, G. 1997: Use of anti-X a activity as a marker for heparin-induced bleeding in patients with APTT > 180 s Clinical Chemistry 43(9): 1781-1782
Krause, I.; Monselise, Y.; Milo, G.; Weinberger, A. 2002: Anti-Saccharomyces cerevisiae antibodies--a novel serologic marker for Behçet's disease Clinical and Experimental Rheumatology 20(4 Suppl 26: S21-S24
Syed Mohamed Suhail, S.M.; Nur Atiqah, I.; Nur Salimi Zakirah, Z.A.; Lailatul Syazwani, Z.; Batis, W.W.; Md Monoto, E.M.; Abdul Wahab, A.; Mohd Shahrir, M.S. 2019: Diagnostic performance of anti-RA33 antibody as a serological marker for rheumatoid arthritis Malaysian Journal of Pathology 41(3): 259-265
Hayem, G.; Chazerain, P.; Combe, B.; Elias, A.; Haim, T.; Nicaise, P.; Benali, K.; Eliaou, J.F.; Kahn, M.F.; Sany, J.; Meyer, O. 1999: Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis Journal of Rheumatology 26(1): 7-13
Nakagawa, C.; Tsukahara, T.; Shimatake, H. 1990: Clinical significance of anti human N-myc protein antibody assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 942-945